N-糖基化对毕赤酵母表达的DSPAα1分泌和活性的影响

Effect of N-linked glycosylation on secretion and activity of recombinant DSPAα1 expressed in Pichia pastoris

摘要:

溶栓剂DSPAα1正处于治疗急性缺血性中风的III期临床研究，临床结果显示DSPAα1具有良好的药理学和安全特性。将DSPAα1基因序列按照毕赤酵母偏好密码子进行优化，并在毕赤酵母菌株GS115和KM71中进行表达，同时利用定点突变对糖基化侧链进行缺失，考察糖基侧链对毕赤酵母表达DSPAα1的影响。结果表明，野生型DSPAα1在GS115和KM71中均获得高表达，在摇瓶发酵条件下，表达量分别为70 mg/L和105 mg/L；利用SDS-PAGE对DSPAα1三种突变体 (N117Q、N362Q和N117

Abstract:

The thrombolytic agent DSPAα1 is currently undergoing clinical trials for the treatment of acute ischemic stroke and has shown good pharmacodynamic, pharmacokinetic and safety profiles. Here, the DSPAα1 gene, optimized for the preferred codons of yeast, was cloned into the Pichia pastoris strains GS115 and KM71. Both expression systems produced functional DSPAα1 into the broth medium under shaking flask growth conditions with the yield of about 70 mg/L, and 105 mg/L, respectively. In addition, three glycosylation minus DSPAα1 mutants, constructed by site-directed mutagenesis, were also expressed in Pichia pastoris. The mutant proteins were assayed by SDS-PAGE and fibrin degradation activities were evaluated. The secretion levels of all the mutants, especially N362Q and N117Q/N362Q, were so lower compared to the wild-type DSPAα1 that only minimal quantities of mutant protein could be recovered by purification from the culture medium. The protein specific activities from mutants (N117Q, N362Q) were less 25% than that of the wild type protein. These results imply that the N-linked carbohydrate chains (at N117 and N362) are vital for the enzymatic activity of rDSPAα1 and for its secretion from Pichia pastoris.